For publication: Tiagabine in the discontinuation of long-term benzodiazepine use.
Oulis
Panagiotis
P
Masdrakis
Vasilios G
VG
Karapoulios
Evangelos
E
Karakatsanis
Nikolaos A
NA
Kouzoupis
Anastasios V
AV
Papadimitriou
George N
GN
D000368:Aged; D001008:Anxiety Disorders / Q000150:complications / Q000188:drug therapy; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D001960:Bromazepam / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D018755:GABA Agonists / Q000627:therapeutic use*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects* / Q000627:therapeutic use; D009557:Nipecotic Acids / Q000627:therapeutic use*; D011569:Psychiatric Status Rating Scales; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*; D000078308:Tiagabine
D018755:GABA Agonists; D006993:Hypnotics and Sedatives; D009557:Nipecotic Acids; D001569:Benzodiazepines; D001960:Bromazepam; D000078308:Tiagabine